The answer to this question is that no one knows. There are many theories. Alpha 1 blockers are considered the drugs of choice for BPH, doxazosin, terazosin, alfuzosin, tamsulosin and silodosin [4]. This suggests that sympathetic dysfunction is involved in BPH. Finasteride and dutasteride have been shown in clinical trials to improve the symptoms of BPH [5]. These drugs inhibit 5-alphareductase also called 3-oxo-5α-steroid 4-dehydrogenase, which converts testosterone into dihydrotestosterone. This suggests that dihydrotestosterone may cause or contribute to prostatic enlargement. The antimuscarinic agent, tolterodine, can be used in combination with an α 1 blocker to improve BPH symptoms
AbstractSaw palmetto, Serenoa repens, produces berries that are the source of a popular medicine used in the treatment of benign prostatic hyperplasia, prostate infections, prostatitis, chronic pelvic pain syndrome, prostate cancer, hypotonic neurogenic bladder, sexual dysfunction and other conditions. Several clinical trials have been conducted with various extracts of the plant. The results have been mixed. Metaanalyses and systematic reviews of the trials have concluded that S. repens appears to be effective in the treatment of benign prostatic hyperplasia. The mechanism of action of the medicine is not clear. This review discusses the possibility that medium length fatty acids from S. repens decrease the inflammation of the prostate by altering adipokine secretion from visceral fat. This leads to less hyperplasia and perhaps less risk of promoting prostate cancer.